Paul, B., Tan, C., Geyer, S., Pederson, L., Schumacher, P., Kennedy, C., Semmel, E., James, S., Cleaves, T., Zanwar, S., Schroeder, M., Zonder, J., Martin, T., Nooka, A., D'Souza, A., Richard, S., Sperling, A., Rosenberg, A., Rubinstein, S., Usmani, S., Hashmi, H., Bhutani, M. (2025). Defining functional high-risk multiple myeloma in the era of modern induction therapy. Blood. https://doi.org/10.1182/blood-2025-4014